KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHC) Depreciation & Amortization (CF) (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $62.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 20.0% year-over-year to $62.0 million, compared with a TTM value of $261.9 million through Dec 2025, down 8.08%, and an annual FY2025 reading of $261.9 million, down 8.08% over the prior year.
  • Depreciation & Amortization (CF) was $62.0 million for Q4 2025 at Diversified Healthcare Trust, down from $65.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $83.7 million in Q4 2023 and bottomed at $57.3 million in Q1 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $67.1 million, with a median of $67.6 million recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 32.04% in 2023, then dropped 20.0% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $68.4 million in 2021, then decreased by 7.36% to $63.4 million in 2022, then soared by 32.04% to $83.7 million in 2023, then decreased by 7.35% to $77.5 million in 2024, then dropped by 20.0% to $62.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for DHC at $62.0 million in Q4 2025, $65.3 million in Q3 2025, and $66.3 million in Q2 2025.